230
Participants
Start Date
February 28, 2009
Primary Completion Date
November 30, 2009
Study Completion Date
December 31, 2009
aplindore MR tablets or Placebo
aplindore MR tablets administered QD for about 4 weeks
Wake Research Associates, Raleigh
Coastal Carolina Research Center, Mt. Pleasant
Neurotrials Research, Inc., Atlanta
University Clinical Research Deland, LLC, DeLand
MD Clinical, Hallandale
Miami Research Associates, South Miami
University Clinical Research, Pembroke Pines
Broward Research Group, Pembroke Pines
Tampa Bay Medical Research, Clearwater
Community Research & Sleep Management Institute, Crestview Hills
North Star Medical Research, LLC, Middleburg Heights
Comunity Reasearch, Cincinnati
Tri-State Sleep Disorders Center, Cincinnati
Quest Research Institute, Bingham Farms
Sleep & Behavior Medicine Institute, Vernon Hills
Sleep Medicine and Research Center - St Luke's Hospital, Chesterfield
Lynn Health Science Institute, Oklahoma City
Sleep Medicine Associates of Texas, P.A., Dallas
Paragon Research Center, San Antonio
Lynn Institute of Pueblo, Pueblo
HOPE Research Institute, Phoenix
Genova Clinical Research, Tuscon
Excell Research, Inc., Oceanside
Gaylord Sleep Medicine, Wallingford
Lead Sponsor
Neurogen Corporation
INDUSTRY